These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 10336495)

  • 1. Identification of nuclear receptor corepressor as a peroxisome proliferator-activated receptor alpha interacting protein.
    Dowell P; Ishmael JE; Avram D; Peterson VJ; Nevrivy DJ; Leid M
    J Biol Chem; 1999 May; 274(22):15901-7. PubMed ID: 10336495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear receptor corepressor-dependent repression of peroxisome-proliferator-activated receptor delta-mediated transactivation.
    Krogsdam AM; Nielsen CA; Neve S; Holst D; Helledie T; Thomsen B; Bendixen C; Mandrup S; Kristiansen K
    Biochem J; 2002 Apr; 363(Pt 1):157-65. PubMed ID: 11903058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor-interacting protein 140 interacts with and inhibits transactivation by, peroxisome proliferator-activated receptor alpha and liver-X-receptor alpha.
    Miyata KS; McCaw SE; Meertens LM; Patel HV; Rachubinski RA; Capone JP
    Mol Cell Endocrinol; 1998 Nov; 146(1-2):69-76. PubMed ID: 10022764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p300 functions as a coactivator for the peroxisome proliferator-activated receptor alpha.
    Dowell P; Ishmael JE; Avram D; Peterson VJ; Nevrivy DJ; Leid M
    J Biol Chem; 1997 Dec; 272(52):33435-43. PubMed ID: 9407140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The atypical interaction of peroxisome proliferator-activated receptor alpha with liver X receptor alpha antagonizes the stimulatory effect of their respective ligands on the murine cholesterol 7alpha-hydroxylase gene promoter.
    Gbaguidi GF; Agellon LB
    Biochim Biophys Acta; 2002 Jul; 1583(2):229-36. PubMed ID: 12117567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A regulatory role for RIP140 in nuclear receptor activation.
    Treuter E; Albrektsen T; Johansson L; Leers J; Gustafsson JA
    Mol Endocrinol; 1998 Jun; 12(6):864-81. PubMed ID: 9626662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptors and retinoic acid receptors differentially control the interactions of retinoid X receptor heterodimers with ligands, coactivators, and corepressors.
    DiRenzo J; Söderstrom M; Kurokawa R; Ogliastro MH; Ricote M; Ingrey S; Hörlein A; Rosenfeld MG; Glass CK
    Mol Cell Biol; 1997 Apr; 17(4):2166-76. PubMed ID: 9121466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the transcriptional activity of the peroxisome proliferator-activated receptor alpha by phosphorylation of a ligand-independent trans-activating domain.
    Juge-Aubry CE; Hammar E; Siegrist-Kaiser C; Pernin A; Takeshita A; Chin WW; Burger AG; Meier CA
    J Biol Chem; 1999 Apr; 274(15):10505-10. PubMed ID: 10187842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The short heterodimer partner receptor differentially modulates peroxisome proliferator-activated receptor alpha-mediated transcription from the peroxisome proliferator-response elements of the genes encoding the peroxisomal beta-oxidation enzymes acyl-CoA oxidase and hydratase-dehydrogenase.
    Kassam A; Capone JP; Rachubinski RA
    Mol Cell Endocrinol; 2001 May; 176(1-2):49-56. PubMed ID: 11369442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acyl-CoA esters antagonize the effects of ligands on peroxisome proliferator-activated receptor alpha conformation, DNA binding, and interaction with Co-factors.
    Elholm M; Dam I; Jorgensen C; Krogsdam AM; Holst D; Kratchmarova I; Gottlicher M; Gustafsson JA; Berge R; Flatmark T; Knudsen J; Mandrup S; Kristiansen K
    J Biol Chem; 2001 Jun; 276(24):21410-6. PubMed ID: 11279171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo stabilization of nuclear retinoid X receptor alpha in the presence of peroxisome proliferator-activated receptor alpha.
    Tanaka N; Hora K; Makishima H; Kamijo Y; Kiyosawa K; Gonzalez FJ; Aoyama T
    FEBS Lett; 2003 May; 543(1-3):120-4. PubMed ID: 12753917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-talk between orphan nuclear hormone receptor RZRalpha and peroxisome proliferator-activated receptor alpha in regulation of the peroxisomal hydratase-dehydrogenase gene.
    Winrow CJ; Capone JP; Rachubinski RA
    J Biol Chem; 1998 Nov; 273(47):31442-8. PubMed ID: 9813056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrate and statin synergistically increase the transcriptional activities of PPARalpha/RXRalpha and decrease the transactivation of NFkappaB.
    Inoue I; Itoh F; Aoyagi S; Tazawa S; Kusama H; Akahane M; Mastunaga T; Hayashi K; Awata T; Komoda T; Katayama S
    Biochem Biophys Res Commun; 2002 Jan; 290(1):131-9. PubMed ID: 11779144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The specificity of interactions between nuclear hormone receptors and corepressors is mediated by distinct amino acid sequences within the interacting domains.
    Cohen RN; Brzostek S; Kim B; Chorev M; Wondisford FE; Hollenberg AN
    Mol Endocrinol; 2001 Jul; 15(7):1049-61. PubMed ID: 11435607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A natural polymorphism in peroxisome proliferator-activated receptor-alpha hinge region attenuates transcription due to defective release of nuclear receptor corepressor from chromatin.
    Liu MH; Li J; Shen P; Husna B; Tai ES; Yong EL
    Mol Endocrinol; 2008 May; 22(5):1078-92. PubMed ID: 18292238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subtype- and response element-dependent differences in transactivation by peroxisome proliferator-activated receptors alpha and gamma.
    Kassam A; Hunter J; Rachubinski RA; Capone JP
    Mol Cell Endocrinol; 1998 Jun; 141(1-2):153-62. PubMed ID: 9723896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The peroxisome proliferator response element of the gene encoding the peroxisomal beta-oxidation enzyme enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase is a target for constitutive androstane receptor beta/9-cis-retinoic acid receptor-mediated transactivation.
    Kassam A; Winrow CJ; Fernandez-Rachubinski F; Capone JP; Rachubinski RA
    J Biol Chem; 2000 Feb; 275(6):4345-50. PubMed ID: 10660604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The orphan nuclear hormone receptor LXR alpha interacts with the peroxisome proliferator-activated receptor and inhibits peroxisome proliferator signaling.
    Miyata KS; McCaw SE; Patel HV; Rachubinski RA; Capone JP
    J Biol Chem; 1996 Apr; 271(16):9189-92. PubMed ID: 8621574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subtype specific effects of peroxisome proliferator-activated receptor ligands on corepressor affinity.
    Stanley TB; Leesnitzer LM; Montana VG; Galardi CM; Lambert MH; Holt JA; Xu HE; Moore LB; Blanchard SG; Stimmel JB
    Biochemistry; 2003 Aug; 42(31):9278-87. PubMed ID: 12899614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.
    Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B
    Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.